These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6961638)

  • 1. The treatment of leprosy in Papua New Guinea.
    Reé GH
    P N G Med J; 1982 Sep; 25(3):142. PubMed ID: 6961638
    [No Abstract]   [Full Text] [Related]  

  • 2. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of leprosy for control programmes.
    World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 5. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis and leprosy--provincial implementation of the new chemotherapies.
    Hudson BJ
    P N G Med J; 1989 Mar; 32(1):1-4. PubMed ID: 2750316
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined therapy in principle and practice for the control of dapsone resistance.
    Rees RJ
    Lepr Rev; 1978 Jun; 49(2):97-100. PubMed ID: 661485
    [No Abstract]   [Full Text] [Related]  

  • 10. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 11. The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):864-71. PubMed ID: 3325580
    [No Abstract]   [Full Text] [Related]  

  • 12. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 13. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control.
    Levy L
    Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale of the multidrug regimens recommended by a World Health Organization Study Group on Chemotherapy of Leprosy for Control Programs.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):395-401. PubMed ID: 6541207
    [No Abstract]   [Full Text] [Related]  

  • 15. Follow-up of smear-positive cases treated with dapsone monotherapy.
    Naik SS; Shere SS
    Indian J Lepr; 1997; 69(2):196-7. PubMed ID: 9290975
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 17. The need for new drugs in the treatment and control of leprosy.
    Baker RJ
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):78-97. PubMed ID: 2181046
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of "Novolep", a by-product of D.D.S., for the treatment of trophic ulcers (planter) in leprosy.
    Mahapatra SB
    Indian J Dermatol; 1975 Oct; 21(1):22-4. PubMed ID: 1234880
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 20. Hansen's disease (leprosy).
    Wariyar B
    Nebr Med J; 1996 May; 81(5):147-8. PubMed ID: 8975147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.